Effects of FABP5 Expression on Clinicopathological and Survival Characteristics in Digestive System Malignancies: A Systematic Review and Meta‐Analysis
Cancer Medicine · 2025-04 · 14 (7)
DOI: 10.1002/cam4.70794 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Medicine, online erschienen am 03.04.2025. Verfasst von Miaoqing Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Laboratory for Clinical Medicine, Beijing YouAn Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Fatty Acid-Binding Proteins, Digestive System Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Beijing Hospitals Authority's Ascent Plan.
Abstract (Originalsprache)
Background
Digestive system malignancies are a major global health burden, and the role of fatty acid binding protein 5 (FABP5) in these tumors remains controversial.
Aims
This meta‐analysis aimed to evaluate the correlation between FABP5 expression and clinicopathological features, as well as survival outcomes in digestive system malignancies. Materials and Methods Data from 11 studies (1207 patients) retrieved from PubMed, Embase, Cochrane Library, CNKI, and WanFang were analyzed.
Results
FABP5 overexpression was associated with poorer overall survival (OS), larger tumor size, advanced UICC stage, and increased risk of vascular invasion and lymph node metastasis. Notably, FABP5 overexpression is particularly associated with poorer OS in the subgroup of digestive tract malignancies and larger tumor sizes in the subgroup of Chinese patients.
Discussion
Cellular experiments demonstrated that FABP5 overexpression enhances proliferation, migration, and invasion in hepatocellular carcinoma (Huh7) and gastric cancer (HGC‐27) cell lines, while FABP5 knockdown reduces these effects. Mechanistically, FABP5 may drive tumor progression through PPARβ/δ signaling, epithelial‐mesenchymal transition induction, angiogenesis regulation, and potential effects on fatty acid metabolism and hypoxia‐related pathways.
Conclusion
FABP5 overexpression correlates with adverse clinicopathological features and prognosis in digestive system malignancies, suggesting its potential as a biomarker for these tumors. Further research is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Laboratory for Clinical Medicine, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
- Department of Clinical Epidemiology Research, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Miaoqing Li, Xiaoxia Wang, Qingkun Song
Förderung
- National Key Research and Development Program of China
- Beijing Hospitals Authority's Ascent Plan
Zitieren
APA
Li, M., Wang, X., Guo, J., Qu, J., Cao, Y., Song, Q., & Lu, J. (2025). Effects of FABP5 Expression on Clinicopathological and Survival Characteristics in Digestive System Malignancies: A Systematic Review and Meta‐Analysis. Cancer Medicine, 14(7). https://doi.org/10.1002/cam4.70794
Vancouver
Li M, Wang X, Guo J, Qu J, Cao Y, Song Q, et al. Effects of FABP5 Expression on Clinicopathological and Survival Characteristics in Digestive System Malignancies: A Systematic Review and Meta‐Analysis. Cancer Medicine. 2025;14(7). doi:10.1002/cam4.70794
BibTeX
@article{Li2025,
author = {Li, Miaoqing and Wang, Xiaoxia and Guo, Jia and Qu, Junchen and Cao, Yu and Song, Qingkun and Lu, Jun},
title = {Effects of FABP5 Expression on Clinicopathological and Survival Characteristics in Digestive System Malignancies: A Systematic Review and Meta‐Analysis},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {7},
doi = {10.1002/cam4.70794}
}
EUVIMED